Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
4,440,602
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
17,460
-
Shares change
-
-116,048
-
Total reported value, excl. options
-
$12,519
-
Value change
-
-$182,221
-
Number of buys
-
2
-
Number of sells
-
3
-
Price
-
$0.7170
Institutional Holders of Virax Biolabs Group Ltd - Ordinary Shares (VRAX) as of Q1 2024
As of 31 Mar 2024 Virax Biolabs Group Ltd - Ordinary Shares (VRAX) had 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,460 shares of stock of the company.
Largest 5 holders included CITADEL ADVISORS LLC, UBS Group AG, WELLS FARGO & COMPANY/MN, ARMISTICE CAPITAL, LLC, and Virtu Financial LLC.
This table shows 5 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.